Immunochemotherapy with OK-432 may improve survival for people with curatively resected gastric cancer: Abstracted from: Sakamoto J, Teramukai S, Nakazato H et al. Efficacy of adjuvant immunochemotherapy with OK-432 for patients with curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials. Journal of Immunotherapy 2002; 25: 405–12.

✍ Scribed by Ilaria Panzini; Lorenzo Gianni; Davide Tassinari

• Book ID: 117487679
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 67 KB
• Volume: 29
• Category: Article
• ISSN: 0305-7372
• DOI: 10.1016/s0305-7372(02)00124-x